Ralph Benedict, PhD, Professor of Neurology at Univ. at Buffalo Jacobs School of Medicine and Biomedical Sciences where he directs the neuropsychology program, has recently published four papers as part of the Multiple Sclerosis Outcomes Assessment Consortium (MSOAC). Dr. Benedict played a lead role in this effort; the consortium includes representatives from the FDA, NIH (NINDS), academia, industry and advocacy organizations. The four papers have been published in the Multiple Sclerosis Journal (See msoac-benedict-msj-2017 for Dr. Benedict’s lead paper) and provide a framework for the FDA to assess outcomes from treatment interventions in multiple sclerosis.
The Univ. at Buffalo/SUNY Department of Neurology, Jacobs Neurological Institute, of the Jacobs School of Medicine and Biomedical Sciences again will have a large presence at the American Academy of Neurology (AAN) Annual Meeting to be held April 22-28, 2017 in Boston. Between scientific and educational sessions, the department will conduct over 30 presentations. Research topics include multiple sclerosis (MS), neuroimaging, stroke, headache, central nervous system malignancies, experimental autoimmune encephalomyelitis (a model for MS), and the history of neurology. Department faculty listed as first, senior or co-authors on the abstracts include Drs. Ralph Benedict, Marilou Ching, Christopher Deline, Michael Dwyer, Edward Fine, David Hojnacki, Amit Kandel, Channa Kolb, Ping Li, Ashkan Mowla, Murali Ramanathan, Melissa Rayhill, Robert Sawyer, Ferdinand Schweser, Bianca Weinstock-Guttman, and Robert Zivadinov. Neurology residents and fellows include Drs. Muhammad Ahmed, Ashish Arora, Hao Cheng, Svetlana Eckert, Rabia Ghazi, Haris Kamal, Rakesh Magun, Sandhya Mehla, Harshit Shah, Brian Trummer, and Daniela Zambrano. Research staff and other collaborators are Rahil Ahmed, Nicola Bertolino, Ellen Carl, Annemarie Crumlish, Jackie Durfee, Sirin Gandhi, Jesper Hagemeier, Dejan Jakimovski, Katelyn Kavak, Navdeep Lail, Clair Modica, Muhammad Nadeem, Deepa Ramasamy, and Michelle Sudyn.
The Dept. of Neurology boasts eight physicians who have been named to the Castle Connolly Top Docs list recently published in the January 2017 issue of Buffalo Spree magazine. The recognition follows screening by a physician-led team of researchers on both the national and regional levels. These are the physicians most highly regarded by their peers. The physicians mentioned as Top Docs are:
Adult neurology: Drs. David Lichter, Robert Sawyer, Kinga Szigeti and Gil Wolfe
Neuro-ophthalmology: Dr. Norah Lincoff (Opthalmology)
Child neurology: Drs. Thomas Langan, Sarah Finnegan, and Arie Weinstock
Gil I. Wolfe, MD, Irvin and Rosemary Smith Professor and Chairman of the Dept. of Neurology, was named the top awardee in the University at Buffalo’s inaugural Clinical Translational Scientific Award Clinical Research Achievement Award contest. The recognized research relates to the international thymectomy trial in non-thymomatous myasthenia gravis (MGTX) that was recently published in the New England Journal of Medicine mgtx-nejm-final-8-11-16. Dr. Wolfe will present findings from the MGTX trial at the annual UB CTSA Forum on March 28, 2017 and will also be nominated for Top 10 recognition at the national Clinical Research Forum which takes place in D.C. in April.
Ashkan Mowla, MD, Assistant Professor of Neurology, has received a Junior Investigator Travel Award from the International Stroke Conference (ISC) for his paper, “Intravenous thrombolysis with alteplase for acute ischemic stroke in patients with thrombocytopenia.” Dr. Mowla will be presenting several abstracts at the upcoming conference to be held in Houston, Texas in February 2017. For more information about the Univ. at Buffalo Dept. of Neurology’s stroke division’s activities at the ISC, see the accompanying story from earlier this month.
The stroke division of the UB Dept. of Neurology will present 5 papers at the upcoming International Stroke Conference to be held February 22-24, 2017 in Houston, TX. Stroke faculty named on the abstracts include Drs. Marilou Ching, Christopher Deline, Amit Kandel, Ashkan Mowla, and Robert Sawyer. Several current and recently graduated housestaff are also listed as authors, including Khaleeq Ahmed, Haris Kamal, Sanhya Mehla, and Aurangzeb Memon. Annemarie Crumlish, research coordinator, and Navdeep Lail, research assistant, played key organizational roles. The presentations include research investigations into the risk of home antiplatelet and subtherapeutic anticoagulant therapy on intravenous (thrombolysis (IV tPA), impact of low platelet counts on IV tPA, and outcomes of stroke occurring during hospitalization.
Melissa Rayhill, MD, Assistant Professor of Neurology at the Univ. at Buffalo Jacobs School of Medicine and Biomedical Sciences and director of the headache program, was recently interviewed by MedPage Today. In a recent study that Dr. Rayhill and colleagues presented at the American Neurological Association meeting held in October 2016, surveys of patients with cluster headache indicated that 86% were accepting of placebo control arms in preventive drug trials. Patients were less accepting of placebo controls in surgical device or abortive drug trials, however. Dr. Rayhill noted that patients’ lack of success with preventive measures likely influenced the higher acceptance rate of placebo in those types of studies. She also emphasized the importance of understanding cluster headache patient preferences to properly design clinical trials for the condition since “cluster headache is one of the most painful conditions known to man.” For further details, please see http://www.medpagetoday.com/clinical-context/migraines/60864